Wells Fargo & Company Axsome Therapeutics, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 27,042 shares of AXSM stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,042

Previous 19,646 37.65%

Holding current value

$2.17 Million

Previous $1.56 Million 38.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$69.39 - $97.64 $513,208 - $722,145	7,396 Added 37.65%	27,042 $2.16 Million
Q4 2023 Feb 09, 2024	BUY	$57.42 - $83.61 $41,572 - $60,533	724 Added 3.83%	19,646 $1.56 Million
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $655,659 - $778,364	-9,468 Reduced 33.35%	18,922 $1.32 Million
Q2 2023 Aug 15, 2023	SELL	$58.41 - $90.35 $2.21 Million - $3.42 Million	-37,878 Reduced 57.16%	28,390 $2.04 Million
Q1 2023 May 12, 2023	SELL	$58.39 - $75.0 $624,656 - $802,350	-10,698 Reduced 13.9%	66,268 $4.09 Million

Q4 2022 Feb 13, 2023	BUY	$39.94 - $79.72 $125,571 - $250,639	3,144 Added 4.26%	76,966 $5.94 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $2.31 Million - $4.48 Million	64,144 Added 662.78%	73,822 $3.29 Million
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $130 - $280	6 Added 0.06%	9,678 $370,000
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $129,781 - $226,651	-5,476 Reduced 36.15%	9,672 $400,000
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $389,214 - $549,718	12,678 Added 513.28%	15,148 $572,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $13,956 - $47,850	-701 Reduced 22.11%	2,470 $81,000
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $216,038 - $313,624	-4,267 Reduced 57.37%	3,171 $214,000
Q1 2021 May 13, 2021	SELL	$55.91 - $81.44 $917,539 - $1.34 Million	-16,411 Reduced 68.81%	7,438 $421,000
Q4 2020 Feb 09, 2021	BUY	$66.31 - $86.52 $647,649 - $845,040	9,767 Added 69.36%	23,849 $1.94 Million
Q3 2020 Nov 05, 2020	SELL	$68.34 - $85.84 $657,362 - $825,694	-9,619 Reduced 40.58%	14,082 $1 Million
Q2 2020 Aug 13, 2020	SELL	$49.87 - $98.69 $1.16 Million - $2.3 Million	-23,321 Reduced 49.6%	23,701 $1.95 Million
Q1 2020 May 14, 2020	BUY	$41.2 - $101.31 $1.94 Million - $4.76 Million	47,022 New	47,022 $2.77 Million

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.44B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Axsome Therapeutics, Inc. Transaction History